A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1084/jem.20141661
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2015
- Urheber
-
Giotopoulos, George
Weyden, Louise van der
Osaki, Hikari
Rust, Alistair G.
Gallipoli, Paolo
Meduri, Eshwar
Horton, Sarah J.
Chan, Wai-In
Foster, Donna
Prinjha, Rab K.
Pimanda, John E.
Tenen, Daniel G.
Vassiliou, George S.
Koschmieder, Steffen
Adams, David J.
Huntly, Brian J. P.
- DOI
-
10.18154/RWTH-CONV-091583
- URN
-
urn:nbn:de:101:1-2018110106010467165067
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Giotopoulos, George
- Weyden, Louise van der
- Osaki, Hikari
- Rust, Alistair G.
- Gallipoli, Paolo
- Meduri, Eshwar
- Horton, Sarah J.
- Chan, Wai-In
- Foster, Donna
- Prinjha, Rab K.
- Pimanda, John E.
- Tenen, Daniel G.
- Vassiliou, George S.
- Koschmieder, Steffen
- Adams, David J.
- Huntly, Brian J. P.
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2015
Ähnliche Objekte (12)
RUNX1 mutations in acute myeloid leukemia
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Functional classification of TP53 mutations in acute myeloid leukemia
A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Evidence for allelic evolution of C-EBP-alpha mutations in acute myeloid leukemia
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
P448: Prognostic impact of somatic CEBPA BZIP domain mutations in acute myeloid leukemia
Molecular characterization of acute myeloid leukemia : prognostic and predictive impact of gene mutations
Differential splicing and allelic imbalance as pathomechanisms of recurring mutations in Acute Myeloid Leukemia
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
RUNX1 mutations in acute myeloid leukemia
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Functional classification of TP53 mutations in acute myeloid leukemia
A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Evidence for allelic evolution of C-EBP-alpha mutations in acute myeloid leukemia
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
P448: Prognostic impact of somatic CEBPA BZIP domain mutations in acute myeloid leukemia
Molecular characterization of acute myeloid leukemia : prognostic and predictive impact of gene mutations
Differential splicing and allelic imbalance as pathomechanisms of recurring mutations in Acute Myeloid Leukemia
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
RUNX1 mutations in acute myeloid leukemia
Chemotherapy resistance-associated mutations in acute myeloid leukemia
Functional classification of TP53 mutations in acute myeloid leukemia
A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Evidence for allelic evolution of C-EBP-alpha mutations in acute myeloid leukemia
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
P448: Prognostic impact of somatic CEBPA BZIP domain mutations in acute myeloid leukemia
Molecular characterization of acute myeloid leukemia : prognostic and predictive impact of gene mutations
Differential splicing and allelic imbalance as pathomechanisms of recurring mutations in Acute Myeloid Leukemia
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia